Benjamin Graham fit · Investissement defensive deep-value
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Benjamin Graham Stock?
Meets only 2/7 Graham criteria — likely overpriced or unstable.
34/100
FPas un fit
2/7 critères validés
Les critères de Benjamin Graham, appliqués à GYRE
P/E ≤ 15
clé—
P/B ≤ 1.5
clé1.5x
Current ratio ≥ 2
6.2x
Debt / Equity ≤ 1
0.0x
Comment GYRE se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$731.67M
PER (TTM)
55.7x
ROIC (TTM)
11.69%
Marge brute
95.48%
Questions fréquentes
What is GYRE's Benjamin Graham fit score?
GYRE scores 34/100 on our Benjamin Graham fit engine — grade F. Meets only 2/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own GYRE?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends GYRE.
How often is this score updated?
GYRE's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Benjamin Graham possède ou recommande GYRE personnellement.